University of Minnesota. Driven to Discover.
The FDA approves the first adjuvanted H5N1 flu vaccine to aid in pandemic preparedness.
New federal contracts establish a "fill and finish" network for flu vaccine to boost capacity by 20%.
Response to seasonal flu, H7N9, MERS, and other threats could be markedly diminished.
Antibiotics stockpiles are in place for an anthrax attack, but will people take the drugs?
HHS awarded $916 million in emergency preparedness grants, down $55 million from last year.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.